Sources | Names Used |
---|---|
CTRPv2 | UNC0638:navitoclax (1:1 mol/mol) |
PharmacoGx | UNC0638:navitoclax (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TUBA1A | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-15 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-14 |
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-14 |
mRNA | TIGD3 | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-14 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-14 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-14 |
mRNA | ATL1 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-14 |
mRNA | SNAP25 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-14 |
mRNA | CAMK2N2 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |